VGX-3100

· Inovio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for VGX-3100, covering 2018-09-07 to 2026-04-29. Get the full timeline:

Most recent: Clinical Trial Results: VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions [Phase 2]